Jinichi Hirano, MD, PhD, is affiliated with the Department of Neuropsychiatry at Keio University School of Medicine in Tokyo, Japan. Hirano has published research on major depressive disorder and electroconvulsive therapy, including studies on predicting remission using clinical features and machine learning. Additional work has focused on schizophrenia and schizoaffective disorders, particularly investigating plasma risperidone levels and dopamine D2 receptor occupancy during maintenance treatment. Frequent collaborators include Masaru Mimura, Akihiro Takamiya, Bun Yamagata, David Mamo, and Fusaka Minami.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
